$1.75 Billion is the total value of Bronte Capital Management Pty Ltd.'s 64 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 9.7% . Bronte Capital Management Pty Ltd. is a registered-investment adviser.
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GOOGL | Buy | ALPHABET INCcap stk cl a | $240,116,000 | +60.7% | 110,182 | +105.1% | 13.76% | +9.6% |
| BRKB | Buy | BERKSHIRE HATHAWAY INC DELcl b new | $232,992,000 | +7884.6% | 853,388 | +1298.0% | 13.35% | +5349.8% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $176,380,000 | +81.7% | 298,378 | +114.6% | 10.11% | +23.9% |
| HLF | Buy | HERBALIFE NUTRITION LTD | $122,564,000 | +36.3% | 5,993,322 | +102.3% | 7.02% | -7.1% |
| V | Buy | VISA INC | $116,530,000 | +751.6% | 591,856 | +270.3% | 6.68% | +480.7% |
| IBKR | Buy | INTERACTIVE BROKERS GROUP | $97,734,000 | +89.0% | 1,776,656 | +126.5% | 5.60% | +28.9% |
| CTVA | Buy | CORTEVA INC | $97,474,000 | +89.5% | 1,800,392 | +101.2% | 5.59% | +29.2% |
| IBB | New | ISHARES TRishares biotech | $66,878,000 | – | 568,538 | +100.0% | 3.83% | – |
| ATVI | Buy | ACTIVISION BLIZZARD INC | $63,970,000 | +95.4% | 821,610 | +101.0% | 3.67% | +33.3% |
| IWO | Sell | ISHARES TRcall | $55,704,000 | -60.4% | 270,000 | -50.9% | 3.19% | -73.0% |
| PINS | Buy | PINTEREST INCcl a | $52,598,000 | +60.3% | 2,896,320 | +117.2% | 3.01% | +9.3% |
| PM | Buy | PHILIP MORRIS INTL INC | $40,372,000 | +179.8% | 782,753 | +409.7% | 2.31% | +90.9% |
| GHC | Buy | GRAHAM HLDGS CO | $36,582,000 | +94.4% | 64,536 | +109.7% | 2.10% | +32.6% |
| HIBB | Buy | HIBBETT INC | $33,134,000 | +380.5% | 758,038 | +387.4% | 1.90% | +228.0% |
| FB | Buy | META PLATFORMS INCcl a | $32,774,000 | +225.1% | 203,250 | +348.3% | 1.88% | +121.7% |
| IWM | Buy | ISHARES TRcall | $31,874,000 | -90.3% | 188,200 | +18.1% | 1.83% | -93.4% |
| STT | Buy | STATE STR CORP | $30,412,000 | +36.8% | 493,292 | +93.3% | 1.74% | -6.7% |
| BK | Buy | BANK NEW YORK MELLON CORP | $29,844,000 | +2244.4% | 715,520 | +5493.9% | 1.71% | +1498.1% |
| SQM | Buy | SOCIEDAD QUIMICA Y MINERA DEspon adr ser b | $27,930,000 | +104.1% | 334,370 | +109.2% | 1.60% | +39.2% |
| SHC | Buy | SOTERA HEALTH CO | $27,102,000 | +59.5% | 1,383,478 | +76.3% | 1.55% | +8.8% |
| GIS | Buy | GENERAL MLS INC | $24,890,000 | +104.3% | 329,878 | +83.4% | 1.43% | +39.3% |
| GOOG | Buy | ALPHABET INCcap stk cl c | $23,816,000 | +44.1% | 10,888 | +83.9% | 1.36% | -1.7% |
| ALB | New | ALBEMARLE CORP | $22,908,000 | – | 109,620 | +100.0% | 1.31% | – |
| MO | Buy | ALTRIA GROUP INC | $19,080,000 | +27.9% | 456,790 | +60.0% | 1.09% | -12.8% |
| MDLZ | Buy | MONDELEZ INTL INCcl a | $9,326,000 | +51.7% | 150,214 | +53.4% | 0.53% | +3.3% |
| MACK | Buy | MERRIMACK PHARMACEUTICALS IN | $6,882,000 | +88.1% | 1,156,626 | +100.0% | 0.39% | +28.3% |
| Sell | BATH & BODY WORKS INC | $6,454,000 | -66.2% | 239,756 | -37.7% | 0.37% | -76.9% | |
| NEM | Buy | NEWMONT CORP | $6,274,000 | +57.3% | 105,148 | +109.5% | 0.36% | +7.5% |
| NPO | Buy | ENPRO INDS INC | $5,020,000 | +68.0% | 61,262 | +100.4% | 0.29% | +14.7% |
| AVLR | Buy | AVALARA INC | $3,950,000 | +210.3% | 55,950 | +337.4% | 0.23% | +111.2% |
| BNTX | Buy | BIONTECH SEsponsored ads | $2,072,000 | +75.1% | 13,896 | +100.4% | 0.12% | +20.2% |
| DBTX | Buy | DECIBEL THERAPEUTICS INC | $1,378,000 | +177.8% | 327,094 | +100.4% | 0.08% | +88.1% |
| XBI | Exit | SPDR SER TRcall | $0 | – | -120,000 | -100.0% | -0.91% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL | 20 | Q3 2023 | 22.6% |
| ALPHABET INC-CL A | 20 | Q3 2023 | 14.4% |
| HERBALIFE NUTRITION LTD | 20 | Q3 2023 | 22.0% |
| INTERACTIVE BROKERS GROUP | 20 | Q3 2023 | 12.4% |
| ALPHABET INC-CL C | 20 | Q3 2023 | 5.7% |
| VISA INC-CLASS A SHARES | 19 | Q2 2023 | 16.6% |
| CORTEVA NC | 17 | Q3 2023 | 6.2% |
| GRAHAM HOLDINGS CO-CLASS B | 13 | Q3 2023 | 2.1% |
| REGENERON PHARMACEUTICALS | 12 | Q3 2023 | 13.0% |
| STATE STREET CORP | 12 | Q2 2023 | 3.0% |
View Bronte Capital Management Pty Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-13 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-03 |
| 13F-HR/A | 2022-08-08 |
| 13F-HR | 2022-08-08 |
| 13F-HR | 2022-05-13 |
View Bronte Capital Management Pty Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.